Susquehanna International Group
GNCA

Susquehanna International Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Susquehanna International Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-67,400
Closed -$84K – 14625
2022
Q1 		$84K Buy
67,400
+14,300
+27% +$15.6K ﹤0.01% 12024
2021
Q4 		$62K Buy
53,100
+33,400
+170% +$49.8K ﹤0.01% 12442
2021
Q3 		$38K Sell
19,700
-41,700
-68% -$82K ﹤0.01% 12437
2021
Q2 		$144K Sell
61,400
-63,700
-51% -$154K ﹤0.01% 11881
2021
Q1 		$339K Buy
125,100
+73,600
+143% +$218K ﹤0.01% 10351
2020
Q4 		$125K Sell
51,500
-28,600
-36% -$65.1K ﹤0.01% 10373
2020
Q3 		$183K Buy
80,100
+63,000
+368% +$165K ﹤0.01% 9529
2020
Q2 		$39K Buy
+17,100
New +$39.4K ﹤0.01% 9817
2019
Q3 		– Sell
-78,400
Closed -$307K – 11299
2019
Q2 		$307K Buy
+78,400
New +$409K ﹤0.01% 8271
2017
Q4 		– Sell
-1,275
Closed -$15K – 10246
2017
Q3 		$15K Buy
+1,275
New +$48.4K ﹤0.01% 8672

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Susquehanna International Group's GNCA Position: Q4 2020 in Review

Susquehanna International Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 56,458 shares — an estimated $129K sold.

Susquehanna International Group first reported a position in GNCA in Q2 2016 and held it in 12 quarters. The position peaked at $271K in Q1 2017. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • Susquehanna International Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 56,458 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $129K.
  • Susquehanna International Group first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 12 quarters.
  • Susquehanna International Group's Genocea Biosciences, Inc. position peaked at $271K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.